Deucravacitinib Interactions
There are 475 drugs known to interact with deucravacitinib, along with 4 disease interactions. Of the total drug interactions, 372 are major, 94 are moderate, and 9 are minor.
- View all 475 medications that may interact with deucravacitinib
- View deucravacitinib disease interactions (4)
Most frequently checked interactions
View interaction reports for deucravacitinib and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Actonel (risedronate)
- Advair Diskus (fluticasone / salmeterol)
- Afrin (oxymetazoline nasal)
- Afrin Sinus (oxymetazoline nasal)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aleve (naproxen)
- Ambien (zolpidem)
- Aspercreme Maximum Strength Lidocaine Patch (lidocaine topical)
- Astepro (azelastine nasal)
- Ativan (lorazepam)
- Atrovent HFA (ipratropium)
- B-12 Dots (cyanocobalamin)
- B-Complex with B-12 (multivitamin)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Benlysta (belimumab)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bimzelx (bimekizumab)
- Bystolic (nebivolol)
- Calcium 600 D (calcium / vitamin d)
- Calcium, Magnesium and Zinc (multivitamin with minerals)
- CellCept (mycophenolate mofetil)
- Citracal + D (calcium / vitamin d)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flax Seed Oil (flax)
- Nexium (esomeprazole)
- Plaquenil (hydroxychloroquine)
- Rinvoq (upadacitinib)
- Vitamin B12 (cyanocobalamin)
- Zyrtec (cetirizine)
Deucravacitinib disease interactions
There are 4 disease interactions with deucravacitinib which include:
Report options
More about deucravacitinib
- deucravacitinib consumer information
- Compare alternatives
- Reviews (13)
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Skyrizi
Skyrizi (risankizumab) is used to treat plaque psoriasis, psoriatic arthritis, ulcerative colitis ...
Stelara
Stelara (ustekinumab) is used to treat Crohn's disease, ulcerative colitis, plaque psoriasis, and ...
Otezla
Otezla (apremilast) is used to treat plaque psoriasis, psoriatic arthritis, and oral ulcers ...
Cosentyx
Cosentyx (secukinumab) is used to treat plaque psoriasis, psoriatic arthritis, ankylosing ...
Humira
Humira is a tumor necrosis factor blocker used to treat many inflammatory conditions in adults ...
Ilumya
Ilumya (tildrakizumab) is used to treat moderate-to-severe plaque psoriasis to reduce plaques ...
Taltz
Taltz (ixekizumab) is used to treat plaque psoriasis, psoriatic arthritis, and ankylosing ...
Tremfya
Tremfya (guselkumab) injection is used to treat plaque psoriasis, psoriatic arthritis, ulcerative ...
Enbrel
Enbrel is used to treat rheumatoid arthritis, ankylosing spondylitis, and psoriasis. Learn about ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
